Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion type Assertion NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_head.
- NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_provenance.
- NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion evidence source_evidence_literature NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_provenance.
- NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion SIO_000772 19434073 NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_provenance.
- NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion wasDerivedFrom gad-20150221 NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_provenance.
- NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_assertion wasGeneratedBy ECO_0000203 NP147193.RAiXA0Wy_hkwwP4tPF_REbAlcPEoYnsS_nH19eB3k2haQ130_provenance.